We take pleasure in announcing the USPTO issuance on May 14, 2019 of Countervail Corporation’s patent for DETECTION OF THE DEGREE OF EXPOSURE TO CHEMICAL WARFARE NERVE AGENTS AND ORGANOPHOSPHATE PESTICIDES WITH LATERAL FLOW ASSAYS.  The technology addressed by this patent will support a novel product that will offer a revolutionary disruptive approach to the current market for organophosphate exposure diagnostic testing.